ZURIVID Trademark

Trademark Overview

On Tuesday, August 13, 2019, a trademark application was filed for ZURIVID with the United States Patent and Trademark Office. The USPTO has given the ZURIVID trademark a serial number of 88576970. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, March 20, 2023. This trademark is owned by Wellstat Therapeutics Corporation. The ZURIVID trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical products and preparations for use in the fields of oncology, mitochondrial disease, neurodegenerative disease and antidotes
zurivid

General Information

Serial Number88576970
Word MarkZURIVID
Filing DateTuesday, August 13, 2019
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, March 20, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 17, 2019

Trademark Statements

Goods and ServicesPharmaceutical products and preparations for use in the fields of oncology, mitochondrial disease, neurodegenerative disease and antidotes

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, August 28, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameWellstat Therapeutics Corporation
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressRockville, MD 20850
Party NameWellstat Therapeutics Corporation
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressRockville, MD 20850

Trademark Events

Event DateEvent Description
Monday, March 20, 2023ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, March 20, 2023ABANDONMENT - NO USE STATEMENT FILED
Friday, July 29, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, July 28, 2022SOU EXTENSION 5 GRANTED
Thursday, July 21, 2022SOU EXTENSION 5 FILED
Thursday, July 21, 2022TEAS EXTENSION RECEIVED
Tuesday, January 25, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, January 24, 2022SOU EXTENSION 4 GRANTED
Thursday, January 20, 2022SOU EXTENSION 4 FILED
Thursday, January 20, 2022TEAS EXTENSION RECEIVED
Tuesday, June 29, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, June 28, 2021SOU EXTENSION 3 GRANTED
Wednesday, June 23, 2021SOU EXTENSION 3 FILED
Wednesday, June 23, 2021TEAS EXTENSION RECEIVED
Thursday, February 4, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, February 3, 2021SOU EXTENSION 2 GRANTED
Wednesday, January 13, 2021SOU EXTENSION 2 FILED
Monday, February 1, 2021CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, January 13, 2021TEAS EXTENSION RECEIVED
Saturday, July 18, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, July 16, 2020SOU EXTENSION 1 GRANTED
Thursday, July 16, 2020SOU EXTENSION 1 FILED
Thursday, July 16, 2020TEAS EXTENSION RECEIVED
Tuesday, February 11, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, December 17, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 17, 2019PUBLISHED FOR OPPOSITION
Wednesday, November 27, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, November 13, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, November 12, 2019ASSIGNED TO EXAMINER
Wednesday, August 28, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, August 16, 2019NEW APPLICATION ENTERED

Related Keywords

zurivid disease neurodegenerative antidotes mitochondrial oncology products preparations fields pharmaceutical